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Abstract: The neuromuscular synapse is a relatively large synapse with hundreds of active zones in
presynaptic motor nerve terminals and more than ten million acetylcholine receptors (AChRs) in the
postsynaptic membrane. The enrichment of proteins in presynaptic and postsynaptic membranes
ensures a rapid, robust, and reliable synaptic transmission. Over fifty years ago, classic studies of the
neuromuscular synapse led to a comprehensive understanding of how a synapse looks and works,
but these landmark studies did not reveal the molecular mechanisms responsible for building and
maintaining a synapse. During the past two-dozen years, the critical molecular players, responsible
for assembling the specialized postsynaptic membrane and regulating nerve terminal differentiation,
have begun to be identified and their mechanism of action better understood. Here, we describe and
discuss five of these key molecular players, paying heed to their discovery as well as describing their
currently understood mechanisms of action. In addition, we discuss the important gaps that remain
to better understand how these proteins act to control synaptic differentiation and maintenance.
Keywords: Agrin; Lrp4; MuSK; Dok-7; Rapsyn; Acetylcholine receptors; motor neurons; ALS;
congenital myasthenia; myasthenia gravis
1. Rock Bottom Synaptic Transmission
Studies by Katz and colleagues established the fundamental mechanisms for synaptic
transmission [1]. Following propagation of an action potential into the nerve terminal, an influx
of calcium stimulates synaptic vesicles, containing ACh, to fuse with the presynaptic membrane,
releasing ACh into the synaptic cleft. ACh binds to densely clustered AChRs in the muscle membrane,
ensuring for rapid, robust and reliable synaptic transmission. The ligand-gated opening of AChR
channels causes focal depolarization of the muscle, which initiates a muscle action potential that
triggers muscle contraction. Following the studies by Katz and colleagues, critical molecules for
building the neuromuscular synapse and concentrating AChRs in the postsynaptic membrane were
identified. Five of these key proteins are discussed here (Figure 1).
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Figure 1. Timeline for the discovery of key molecular players at the neuromuscular synapse. The 
peripheral membrane protein Rapsyn binds to the intracellular region of AChRs and anchors AChRs 
and other muscle proteins in the postsynaptic membrane. Later studies identified Agrin as a critical 
motor neuron-derived signal that is deposited into the synaptic lamina and stimulates the formation 
and maintenance of neuromuscular synapses, including the clustering of AChRs. Shortly thereafter, 
MuSK was identified, shown to mediate the response to Agrin, and found to be critical for both 
postsynaptic and presynaptic differentiation. More than a decade elapsed before the Agrin receptor 
was identified as Lrp4. Lrp4 functions not only to bind Agrin, promoting association between Lrp4 
and MuSK and stimulating muscle differentiation, but also acts in turn as a retrograde signal for 
presynaptic differentiation. During this same time period, Dok-7 was identified and found to bind to 
tyrosine phosphorylated MuSK, stabilize MuSK in an active tyrosine-phosphorylated state and 
function downstream from MuSK. ACh, Acetylcholine. AChRs, Acetylcholine Receptors. ECM, 
Extracellular matrix. MuSK, muscle specific kinase. Lrp4, LDL receptor related protein 4. Dok-7, 
docking protein 7. Bar, 100 nm. 
2. Fundamental Proteins of the Neuromuscular Synapse 
2.1. Agrin 
Although it had long been appreciated that motor neuron-derived factors played an important 
role in postsynaptic differentiation, including clustering of AChRs, the critical neuronal factors 
remained undiscovered through the 1970s. In the 1970s, several labs pursued the characterization 
and purification of soluble factors that were capable of stimulating clustering of AChRs in cultured 
muscle cells, reasoning that these factors either represented or mimicked the signal(s) that motor 
axons supplied to muscle to stimulate clustering of AChRs and postsynaptic differentiation at 
synapses. U.J. McMahan, who had been studying regeneration of neuromuscular synapses, took a 
different view. Because the synaptic extracellular matrix was interposed between the nerve terminal 
membrane and the postsynaptic muscle membrane at adult synapses [1], and because this 
extracellular matrix became apparent at synapses as they form during development [2], McMahan 
proposed that key factors for forming and maintaining synaptic differentiation may be located within 
the synaptic extracellular matrix, or basal lamina. In this view, the key differentiation factors were 
not membrane-bound; instead, the factor(s) were hypothesized to be released by motor axons or 
muscle and to be stably maintained in the synaptic extracellular matrix, where they would act to 
stimulate presynaptic and postsynaptic differentiation. Over the next several years, McMahan’s 
seminal experiments to test these ideas transformed thinking not only about synapse formation but 
also about the role of the extracellular matrix as a stable repository of signals instructive for cellular 
differentiation rather than simply providing structural support to regulate cell shape. 
In the first set of experiments, adult motor axons and myofibers were damaged, leading to 
degeneration of distal motor axons and myofibers, but leaving the muscle fiber basal lamina, 
including the synaptic basal lamina, intact. Despite the absence of nerve terminals and muscle, 
original synaptic sites could be identified, due to the preservation of unique structural features of the 
synaptic basal lamina and the retention of acetylcholinesterase (AChE) in the synaptic basal lamina 
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2.1. Agrin
Although it had long been appreciated that otor neuron-derived factors played an i portant
role in postsynaptic differentiation, including clustering of AChRs, the critical neuronal factors
re ained undiscovered through the 1970s. In the 1970s, several labs pursued the characterization
and purification of soluble factors that ere capable of sti ulating clustering of AChRs in cultured
uscle cells, reasoning that these factors either represented or mimicked the signal(s) that motor axons
supplied to muscle to stimulate clustering of AChRs and postsynaptic differentiation at synapses.
U.J. McMahan, who had been studying regeneration of neuromuscular synapses, took a different view.
Because the synaptic extracellular matrix was interposed between the nerve terminal membrane and
the postsynaptic muscle membrane at adult synapses [1], and because this extracellular matrix became
apparent at synapses as they form during development [2], McMahan proposed that key factors for
forming and maintaining synaptic differentiation may be located within the synaptic extracellular
matrix, or basal lamina. In this view, the key differentiation factors were not membrane-bound;
instead, the factor(s) were hypothesized to be released by motor axons or muscle and to be stably
aintained in the synaptic extracellular matrix, where they would act to stimulate presynaptic and
postsynaptic differentiation. Over the next several years, McMahan’s seminal experiments to test
these ideas transformed thinking not only about synapse formation but also about the role of the
extracellular matrix as a stable repository of signals instructive for cellular differentiation rather than
simply providing structural support to regulate cell shape.
In the first set of experi ents, adult otor axons and yofibers ere da aged, leading to
degeneration of distal motor axons and myofibers, but leaving the muscle fiber basal lamina, including
the synaptic basal lamina, intact. Despite the absence of nerve terminals and muscle, original synaptic
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sites could be identified, due to the preservation of unique structural features of the synaptic basal
lamina and the retention of acetylcholinesterase (AChE) in the synaptic basal lamina [3]. After a
short period of time, motor axons and myofibers regenerated, and regenerated synapses formed
nearly exclusively at original synaptic sites [4]. In the next set of experiments, nerve and muscle were
damaged, but muscle regeneration was prevented. Despite the absence of myofibers, regenerating
motor axons returned selectively to the original synaptic sites, where they differentiated and formed
active zones [5]. These studies indicated that factors, which were stably maintained within the
synaptic basal lamina, could control the differentiation of motor nerve terminals. In the third set
of experiments, following damage to nerve and muscle, motor axon regenerated was prevented.
Despite the absence of motor axons, regenerated myofibers became specialized at original synaptic
sites, where AChRs clustered and postjunctional folds reformed [6]. These studies indicated that
key factors for postsynaptic differentiation were likewise stably maintained in the synaptic basal
lamina and set the stage for purification of these synapse-inducing factors, which were presumed to
be synthesized by nerve and muscle and deposited in the synaptic basal lamina. These factors were
hypothesized to function not only during regeneration but also to act during development to induce
synaptic differentiation during synapse formation [6].
Synapses in the electric organ of Torpedo californica look and function like neuromuscular synapses.
Importantly, because one entire surface of the electrocyte is studded with nerve terminals, whereas only
0.01% of the myofiber membrane is contacted by motor nerve terminals, the enrichment of synaptic
proteins is several thousand-fold greater in the electric organ than in muscle, simplifying purification.
Moreover, it is simple to begin with several kg of electric organ tissue, whereas it would be difficult
to begin with more than several grams of skeletal muscle tissue. For this reason, the electric organ
had been the source for purification of key components of the neuromuscular junction, including
AChRs, AChE, and Rapsyn (see below). Therefore, it seemed reasonable that synaptic basal lamina
components, responsible for synaptic differentiation, would be contained and enriched in the electric
organ as well. Because it was far easier to assay for clustering of AChRs in cultured muscle cells than
formation of active zones in nerve terminals, the studies focused on the extracellular matrix factor(s)
responsible for clustering AChRs. Fractionation and purification of an activity from the electric organ
that stimulated clustering of AChRs in cultured muscle cells led to the identification of a protein
dubbed Agrin [7,8]. Subsequent studies demonstrated that Agrin is present in the synaptic basal
lamina at neuromuscular synapses, as well as at synapses in the electric organ, and plays a critical role
in the formation and maintenance of neuromuscular synapses [9–11].
The Agrin gene encodes a large, ~200 kDa protein with three laminin-G-like domains and four
EGF-like domains contained in the carboxy-terminal half of the protein [11]. The N-terminal region of
Agrin contains a laminin-binding motif, responsible for tethering Agrin to the synaptic basal lamina.
The Agrin gene is expressed in multiple cell types, but neurons express isoforms, containing 8, 11 or
19 amino acids near the carboxy-terminus, generated by alternative splicing, which are critical for
stimulating AChR clustering [12–14]. A 50 kDa carboxy-terminal fragment form of neuronal Agrin,
containing two EGF-like domains and two laminin-G-like domains, is as active as full-length Agrin
when presented to cultured myotubes [15], whereas the N-terminal laminin-binding motif is essential
for Agrin to function in vivo.
Agrin is also expressed in the central nervous system (CNS). Here, Agrin is a type II
transmembrane protein rather than an extracellular matrix protein [16]. The CNS forms of Agrin are
generated by usage of a different promoter, which dictates a different pattern of alternative splicing,
excluding the laminin-binding region and instead encoding a transmembrane segment. The role of
Agrin in the CNS is poorly understood.
2.2. MuSK
The quest for an Agrin receptor began shortly after the discovery of Agrin. A false lead arose
from several studies reporting that α -dystroglycan was the functional receptor for Agrin [17–20].
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However, it soon became clear that although α-dystroglycan can bind neuronal, as well non-neuronal
forms of Agrin, α-dystroglycan was not the functional receptor for Agrin [21–23]. In the 1980s,
it became appreciated that receptor tyrosine kinases (RTKs) often mediate the response to signals
that control cellular differentiation. It therefore seemed plausible that the Agrin receptor might be an
RTK. Consistent with this idea, antibodies to phosphotyrosine showed strong staining at synapses in
muscle and in the electric organ [24]. To identify RTKs that might participate in synaptic differentiation,
degenerate primers were used to amplify RTKs from Torpedo electric organ, reasoning that a synaptic
RTK would be unusually abundant in this synapse-enriched tissue. This assay identified a single,
novel RTK that was particularly abundant in the electric organ and also expressed in muscle [25].
This kinase, dubbed Torpedo RTK, is a single pass transmembrane protein with a kinase domain similar
to that in Trk neurotrophin receptors and an extracellular region with multiple Ig-like domains and a
kringle domain. Subsequent studies pointed to the additional presence of a cysteine-rich, Frizzled-like
domain in the extracellular region [26,27]. In other respects, the amino acid sequence of the electric
organ/muscle RTK appeared unlike any known membrane receptor. Subsequent studies showed
that the mammalian homologue, dubbed MuSK, is enriched at mammalian neuromuscular synapses
and expressed by skeletal muscle but not by motor neurons [28]. Mammalian MuSK contains all of
the domains present in the Torpedo RTK, but mammalian MuSK, unlike fish, amphibian and avian
MuSK, lacks the kringle-like domain [29]. Alternative splicing of MuSK RNA can generate multiple
MuSK isoforms, but the functional significance of these isoforms is not known. Subsequent studies
showed that MuSK is also expressed in the CNS [30,31], but the function of CNS MuSK has not
received due attention. MuSK has also been reported to be expressed by additional cell types [32,33],
but the function of MuSK in these other cell types has likewise not been studied. MuSK, as well as
neuronal Agrin and Lrp4 (see below) are expressed in hepatocellular carcinoma (HCC) cell lines [34].
Activation of MuSK by Agrin enhances cell proliferation, promotes migration, and stimulates tumor
growth. If this HCC tumor model reflects HCC in humans, these findings would suggest that MuSK
signaling contributes to tumorigenesis.
Mice lacking MuSK die at birth from respiratory failure, due to a failure to form neuromuscular
synapses [35]. In the absence of MuSK all features of presynaptic and postsynaptic differentiation fail
to develop [35], indicating that MuSK plays an essential role in synapse formation. AChRs, as well as
other proteins that are normally enriched at synapses, are expressed by muscle but no longer enriched
at synapses in MuSK mutant mice, consistent with the idea that Agrin and MuSK function in the same
signaling pathway. Moreover, synapse-specific transcription also requires MuSK, as ‘synaptic’ genes,
which are normally transcribed preferentially by synaptic myofiber nuclei, are expressed similarly in
all nuclei throughout muscle of MuSK mutant mice [35–37].
Agrin stimulates tyrosine phosphorylation of MuSK in cultured myotubes, demonstrating
that Agrin can activate MuSK [38]. However, ligands that bind directly to RTKs stimulate RTK
phosphorylation within a minute, whereas over five minutes are required for Agrin to stimulate full
phosphorylation of MuSK [38], suggesting that additional steps intercede between Agrin-binding and
stimulation of MuSK kinase activity. Indeed, Agrin binds MuSK only very weakly [39], and fails to
stimulate MuSK phosphorylation in transfected non-muscle cells expressing MuSK [38]. Together,
these studies indicated that although MuSK transduces the Agrin signal, MuSK is not itself an
Agrin receptor.
Surprisingly little is known about the mechanisms by which MuSK mediates the clustering and
anchoring of postsynaptic proteins as well as synapse-specific transcription. Once the activation loop
tyrosine residues in the MuSK kinase domain, as well as a single tyrosine residue in the juxtamembrane
region, are phosphorylated, MuSK becomes an active kinase [40–42]. Phosphorylation of the tyrosine
in the MuSK juxtamembrane region leads to recruitment of a key adapter protein, downstream of
kinase-7 (Dok-7; see below), which is thought to have two essential roles: (1) to maintain MuSK
tyrosine phosphorylation, necessary to sustain MuSK kinase activity and (2) to function as a substrate
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for MuSK kinase, promoting recruitment of two further adapters, Crk and Crk-L, to two tyrosine
phosphorylated motifs in the carboxy-terminal region of Dok-7 (see below).
There is good evidence that actin remodeling participates in clustering of AChRs. Stimulation of
MuSK by Agrin activates Rac and Rho, and they play an important role in the formation of micro- and
macroclusters of AChRs that form in cultured myotubes [43,44]. Moreover, actin polymerization and
regulators of F-actin assembly, such as Cortactin, together with an Arp2/3 complex, are enriched at
AChR clusters in cultured muscle cells [45,46]. How these pathways are activated by MuSK and how
actin and actin regulators act to assist in the anchoring of postsynaptic proteins is not understood.
Additional proteins, including Magi-1c, a protein with a PDZ-binding domain, and two different
E3 ubiquitin ligases, one containing a PDZ-binding domain, can bind to the intracellular region of
MuSK [47,48], but the physiological significance of these interactions is not understood. The collagen
Q (ColQ) subunit of AChE can bind to the extracellular region of MuSK [49], raising the possibility
that this association, together with the strong binding between ColQ and Perlecan, an extracellular
matrix protein, may assist in anchoring the ColQ form of AChE to the synaptic basal lamina.
MuSK is required to maintain as well as to form neuromuscular synapses, since reducing
MuSK expression by RNAi or by conditional gene inactivation in adult myofibers leads to synaptic
disassembly [50,51]. Moreover, rabbits and mice immunized with MuSK show reduced AChR surface
expression and impaired synaptic transmission, which lead to muscle weakness, akin to deficits found
in MuSK myasthenia gravis (MG) (see below) [52,53]. Consistent with the idea that MuSK functions to
maintain as well as to form neuromuscular synapses, approximately 15% of patients with MG have
autoantibodies to MuSK, and passive transfer of these antibodies disrupts the mouse neuromuscular
junction and induces muscle weakness [54–56].
In addition to postsynaptic defects, motor axons fail to stop and differentiate in MuSK mutant
mice, indicating that MuSK not only plays a muscle autonomous role in postsynaptic differentiation
but also has a non-autonomous role in presynaptic differentiation. How MuSK is thought to participate
in presynaptic differentiation will be discussed below (see Section 2.3).
2.3. Lrp4
The discovery of MuSK revealed much about the mechanisms by which Agrin stimulates
postsynaptic differentiation. However, because Agrin does not bind directly to MuSK [38], it remained
unclear how Agrin stimulated MuSK and initiated the MuSK-mediated transduction pathway. Once it
was established that MuSK played a critical role downstream from Agrin, a dozen years passed while
multiple labs hunted for the Agrin receptor, which presumably had a key role in activating MuSK.
A recessive screen for genes required for early steps in mouse development identified two mutant
alleles of Lrp4 [57]. These Lrp4 null mutants had the expected digit defects, due to a loss of
Lrp4 function, but in addition, the Lrp4 mutant mice died at birth due to respiratory failure [57].
Further characterization revealed deficits in neuromuscular synapse formation that resembled the
abnormalities found in Agrin and MuSK mutant mice, raising the possibility that Lrp4 functioned in
the Agrin/MuSK signaling pathway [57]. Consistent with this idea, Lrp4 RNA is expressed in the
central, synaptic region of muscle, like MuSK RNA [58], but not in developing motor neurons [57].
Subsequent studies demonstrated that Lrp4 is the functional muscle receptor for neuronal
Agrin [39,59]. These studies showed that Lrp4 binds neuronal Agrin, forms a complex with MuSK and
functions as a ligand to stimulate MuSK phosphorylation [39,59–61].
Lrp4 is a single-pass transmembrane protein composed of eight low-density lipoprotein
receptor domain class A (LDLa) repeats, two epidermal growth factor (EGF)-like domains, and four
beta-propeller (BP) domains, each of which is melded together with an EGF-like domain [29].
Neuronal Agrin binds to the first BP domain, although the last few LDLa repeats contribute to
Agrin-binding [60,61]. The third BP domain has a critical role in binding of Lrp4 to MuSK [60,62,63].
Association between Lrp4 and MuSK, which is enhanced by binding of Agrin to Lrp4, is mediated,
at least in part, by the first Ig-like domain in MuSK [60]. Thus, the extracellular region of Lrp4 contains
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all of the motifs necessary for Lrp4 to bind Agrin and associate with MuSK [60,64]. The intracellular
region of MuSK is not required for neuromuscular synapse formation but has an important role for
Lrp4 to regulate digit formation [64–66].
Consistent with biochemical studies, which identified domains in Lrp4 and MuSK that mediate
their association, pathogenic autoantibodies to MuSK, which cause MG, bind the first Ig-like
domain in MuSK, thereby inhibiting binding between Lrp4 and MuSK and reducing MuSK tyrosine
phosphorylation [67,68]. Moreover, although certain mutations in human Lrp4 cause Cenani-Lenz
syndrome [69,70], characterized by bone malformations, other mutations in Lrp4, notably in one face
of the third BP domain, impair binding to MuSK and cause congenital myasthenia [62,63].
Lrp4, like other postsynaptic proteins, becomes concentrated and anchored in the postsynaptic
membrane as a consequence of MuSK signaling. As such, Lrp4 functions both upstream and
downstream from MuSK. Once clustered by MuSK signaling, Lrp4 functions as a retrograde signal for
presynaptic differentiation (see below), as Lrp4 is necessary and sufficient to induce differentiation
of motor nerve terminals [71]. This third function of Lrp4, in addition to its function as an Agrin
receptor and a MuSK ligand, is mediated by the LDLa repeats in Lrp4 [71]. The receptor for Lrp4,
which functions in motor neurons to control presynaptic differentiation, has yet to be identified.
Lrp4, like Agrin and MuSK, is expressed in the CNS. Although the roles for Agrin and MuSK
in the CNS are not well understood, several studies have demonstrated that Lrp4 has an important
role in the development of CNS synapses [72–75]. How Lrp4 functions to control CNS development
is not understood. Although one study reported that the alpha3 Na/K ATPase is the CNS receptor
for Agrin [76], Lrp4 may function in the CNS, like in muscle, as the receptor for Agrin. In addition,
because Lrp4 can stimulate presynaptic differentiation in cultured cortical neurons [77], it remains
possible that mechanisms shared with neuromuscular synapses underlie, at least in part, the function
of Lrp4 in the CNS.
2.4. Dok-7
Studies, which sought to identify regions of MuSK that are important for MuSK function, showed
that a phosphotyrosine-binding (PTB) site in the MuSK juxtamembrane region plays a critical role in
MuSK-dependent signaling [40,41]. These studies showed that muscle cells, which expressed MuSK
with mutations in the core motif (NPXY) of the PTB site, which either substituted phenylalanine for
tyrosine and prevented phosphorylation of the PTB site or modified other core residues in the PTB
site to block recruitment of PTB domain-containing proteins, failed to cluster AChRs in response to
Agrin. These findings suggested that tyrosine phosphorylation of the PTB site led to recruitment of a
PTB domain-containing protein that was essential for signaling downstream from MuSK. Surprisingly,
these mutations in the PTB site also prevented Agrin from stimulating phosphorylation of the
three activation loop tyrosine residues in MuSK [41]. Because mutation of the PTB site blocked
MuSK tyrosine phosphorylation in muscle cells, but not in vitro [41], the PTB site did not appear
to have an intrinsic, intramolecular role in regulating MuSK tyrosine kinase activity, as described
for the PTB site in EphB receptors [78]. Instead, these studies suggested that recruitment of a PTB
domain-containing protein to tyrosine phosphorylated MuSK in muscle was necessary to stabilize
MuSK tyrosine phosphorylation, which was critical for MuSK to stimulate AChR clustering and
postsynaptic differentiation. The PTB site in MuSK had the canonical NPXY motif, but the sequence
N-terminal to the core NPXY motif was dissimilar to PTB sites for well-known PTB domain-containing
proteins, suggesting that MuSK recruited a novel PTB domain-containing protein.
The Yamanashi group had studied PTB domain-containing proteins that were members of the Dok
family, and they searched databases for additional, unannotated Dok proteins. They identified a new
family member, Dok-7, which is selectively expressed in skeletal and heart muscle, and showed that
Dok-7 binds the tyrosine phosphorylated PTB site in MuSK [79]. In a single, comprehensive and elegant
study, Okada et al. [79] not only identified Dok-7, but also demonstrated that Dok-7: (1) binds the PTB
site in MuSK; (2) is recruited to MuSK following Agrin-stimulated MuSK tyrosine phosphorylation;
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(3) is concentrated at neuromuscular synapses in vivo; and (4) is essential for neuromuscular synapse
formation in vivo.
Further studies provided insight into how Dok-7 works. Dok-7 is a 55 kDA protein and a member
of the Dok adaptor protein family that consist of a N-terminal pleckstrin-homology (PH) domain,
a PTB domain and Src homology 2 (SH2) domain target motifs in the carboxy-terminal region [80].
The PH/PTB domains in Dok-7 mediate binding to the tyrosine phosphorylated juxtamembrane region
of MuSK [79,81]. In addition, the PH/PTB domains of Dok-7 mediate homodimerization of Dok-7 [82].
The Dok-7 carboxy-terminal region contains two tyrosine residues, Y396 and Y406, that are
phosphorylated following recruitment of Dok-7 to tyrosine phosphorylated MuSK [81,83].
The sequences surrounding these tyrosine residues conform to SH2-binding sites, and once
phosphorylated, they recruit Crk and Crk-L, adapter proteins containing SH2 and SH3 domains [81,83].
A common and simple way to assess Dok-7 function is to introduce wild-type or mutant forms
of Dok-7 into muscle or non-muscle cells by transfection. Over-expression of Dok-7 in cultured
muscle cells stimulates MuSK tyrosine phosphorylation and AChR clustering, even in the absence
of Agrin stimulation. AChRs fail to cluster in muscle cells transfected with mutant forms of Dok-7
(Dok-7 396F; 406F), which cannot be tyrosine phosphorylated and recruit Crk/Crk-L, suggesting that
recruitment of Crk/Crk-L plays an important role in clustering AChRs [81,83]. However, because
Dok-7 overexpression leads to MuSK activation and AChR clustering, even in the absence of Agrin
stimulation, these studies should be interpreted with caution as they may not reflect the mechanisms
by which Dok-7 normally acts in vivo. Muscle-conditional inactivation of Crk and Crk-L leads to
synaptic defects [83], consistent with the findings from Dok-7 over-expression in cultured muscle cells,
but these defects could be due to a loss of binding between Crk/Crk-L and Dok-7 or a loss of other
functions for Crk/Crk-L in muscle.
Agrin fails to stimulate MuSK tyrosine phosphorylation in muscle cells lacking Dok-7 [84].
These findings, which are consistent with prior studies showing that the MuSK PTB site is required
for MuSK phosphorylation, indicate that binding between Dok-7 and tyrosine phosphorylated
MuSK stabilizes MuSK tyrosine phosphorylation [41]. Structural studies, which show that Dok-7
functions as a dimer to promote MuSK dimerization and trans-phosphorylation, support this idea
and provide a mechanistic understanding to explain how Dok-7 might participate to stabilize MuSK
phosphorylation [82]. Thus, Dok-7 appears to function, at least in part, as an inside-out ligand to
stabilize and promote MuSK tyrosine phosphorylation.
Although the carboxy-terminal region of Dok-7 is not essential for Dok-7 to stimulate MuSK
tyrosine phosphorylation, the carboxy-terminal region of Dok-7 is required to stimulate maximal
MuSK tyrosine phosphorylation in vitro [85]. The mechanism by which the carboxy-terminal region of
Dok-7 contributes to stimulate MuSK phosphorylation is not understood. The carboxy-terminal region,
which is likely unstructured, may stabilize a Dok-7 dimer and thereby facilitate MuSK phosphorylation.
The role of the Dok-7 carboxy-terminal region in stimulating MuSK phosphorylation is only evident in
myotubes and not in heterologous cells or myoblasts. These data suggest that Dok-7-dependent MuSK
activation in myotubes is regulated by a cell type-specific mechanism that is not yet understood [41,85].
Approximately, 10–15% of patients diagnosed with congenital myasthenia carry mutations
in Dok-7 [86–88]. Certain disease-causing mutations in Dok-7 impair the ability of Dok-7 to bind
MuSK, while other mutations reduce Dok-7 dimerization [89], each leading to a reduction in AChR
clustering [87]. The most common mutation is a four-bp duplication (1124_1127 TGCC), which leads to
a frame-shift and premature truncation of Dok-7, resulting in a loss of the two carboxy-terminal tyrosine
residues [86,90]. Although neuromuscular synapses are structurally and functionally impaired in
patients who are homozygous for this mutation, the mutation does not cause lethal respiratory failure.
As such, this mutation, which eliminates the two carboxy-terminal tyrosine residues, is not a loss of
function mutation, indicating that the PH/PTB domains of MuSK, which mediate Dok-7 dimerization
and promote MuSK tyrosine phosphorylation are alone able to stimulate, albeit incomplete, synaptic
differentiation. These findings suggest that MuSK phosphorylation is ‘sensed’ by additional proteins,
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which bind either to MuSK or to the PH/PTB domains in Dok-7 and participate in signaling
downstream from MuSK.
Like MuSK mRNA, Dok-7 mRNA is enriched in the central region of developing muscle at
E14.5 [84]. This enrichment of Dok-7 RNA, and presumably Dok-7 protein, likely contribute to
MuSK activation and muscle pre-patterning. However, this enrichment of Dok-7 mRNA in the
central region of muscle is transient, and by E18.5, Dok-7 mRNA, unlike MuSK and AChR mRNAs,
is uniformly expressed in muscle [84], indicating that the Dok-7 gene is not a target of MuSK signaling.
The enrichment of Dok-7 mRNA at E14.5 may be a consequence of the pattern of muscle growth:
because myoblasts fuse at the growing ends of the myotube, genes that are activated following
myoblast fusion are expressed for a longer period of time in the central region of muscle, allowing for
their transcripts to accumulate.
Dok-7 can shuttle between the nucleus and the cytoplasm [81]. The PH-domain of Dok-7
confers nuclear import, whereas the carboxy-terminal region contains a nuclear export signal (NES),
which ensures that Dok-7 is translocated to the cytoplasm. Dok-7 is not known to have a nuclear
function. Mutation of the nuclear export signal leads to accumulation of Dok-7 in the nucleus,
which diminishes MuSK tyrosine phosphorylation and AChR clustering [81]. It remains possible that
mutations in the carboxy-terminal region of human Dok-7, which truncate Dok-7 and lead to a loss of
the NES, cause congenital myasthenia (see below) by impairing Dok-7 translocation to the cytoplasm.
2.5. Rapsyn
Rapsyn is a peripheral membrane protein that binds directly to skeletal muscle AChRs. Only two
other proteins, Src-family kinases and adenomatous coli (APC) polyposis, have been reported to
bind directly to AChRs. Src-family kinases have a role in stabilizing AChRs [91], whereas the role of
APC in synaptic differentiation is poorly understood. In contrast, Rapsyn plays an essential role in
anchoring postsynaptic proteins, including AChRs, in the postsynaptic membrane. Although Rapsyn
was identified as an AChR-associated protein in the 1970s [92], long before the discovery of Agrin,
Lrp4, MuSK, or Dok-7 (Figure 1), surprisingly little is known about how Rapsyn functions to anchor
postsynaptic proteins. Difficulties in isolating purified, soluble, well-folded Rapsyn likely underlie
the absence of structural information about Rapsyn. Moreover, Rapsyn-associated proteins likely
play an important role in providing a scaffold for anchoring postsynaptic proteins, but very few
Rapsyn-associated proteins have been identified, and none have been shown to play a key role in
anchoring AChRs or other postsynaptic proteins (Figure 1).
Rapsyn co-isolates with AChR-rich postsynaptic membranes and was initially thought to be a
subunit of the AChR and to contribute to the ion channel [92]. Biochemical as well as reconstitution
experiments from bona fide AChR subunit mRNAs demonstrated that Rapsyn is neither an integral
nor a necessary subunit of the AChR, but instead binds to the main intracellular loop, between the
third and fourth transmembrane segments, of AChR subunits [93,94]. Rapsyn can bind each of the four
AChR subunits [95]. In addition, following Agrin stimulation, the AChR β subunit becomes tyrosine
phosphorylated [24], leading to recruitment of Rapsyn to the tyrosine phosphorylated AChR β subunit
and therefore additional Rapsyn to the AChR complex [96].
Rapsyn is a myristolylated 43 kd protein with three notable domains: seven tetratrichopeptide
(TPR) repeats, which constitute the N-terminal half of the protein; a coiled-coil region; and a C-terminal
RING finger domain [97–99]. The coiled-coil region binds AChR subunits and is also required for
Rapsyn to bind alpha-actinin [100]. The RING finger domain possesses catalytic activity that promotes
neddylation of AChR subunits [101], and in addition, the RING finger domain binds dystroglycan [99].
The TPR repeats are thought to mediate oligomerization of Rapsyn [98], and in addition, they bind
Macf1, a scaffolding protein that contains spectrin-like repeats as well as binding sites for microtubules
and actin [102].
The thirty-four amino acid TPR repeat adopts a helix-turn-helix fold, and in proteins with
multiple TPR repeats, the TPR repeats form a super-helical structure with the concave surface usually
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involved in ligand-binding. The shape of the super-helical structure depends upon residues that are
interposed between adjacent TPR repeats. TPR repeats can mediate dimerization and oligomerization
of TPR domain-containing proteins as well as binding to ligands [103,104]. In PEX5, the seven TPR
repeats fold to form two subdomains, composed of TPR repeats 1–3 and 5–7, separated by a flexible
TPR repeated 4. The cavity formed between the two subdomains binds cargo for import into the
peroxisome [105]. Rapsyn also contains seven TPR repeats, so it is interesting to speculate that Rapsyn
may adopt a structure akin to PEX5 and bind ligands in an analogous manner. However, instead of
forming a cavity, the TPR repeats in Rapsyn may adopt a more extended and open configuration,
promoting association between TPR repeats in adjacent Rapsyn molecules, thereby contributing to
Rapsyn oligomerization. Knowledge of the structure of Rapsyn would be an important step in to
understanding how Rapsyn functions.
In the absence of Rapsyn, AChRs fail to cluster and mice die perinatally [106]. Unlike Agrin, Lrp4,
MuSK, and Dok-7, Rapsyn functions exclusively in the post-translational anchoring pathway and not
in the synapse-specific transcription pathway. As such, in the absence of Rapsyn, like in wild-type mice.
AChR and other ‘synaptic’ transcripts are enriched in the synaptic region [106]. Synaptic extracellular
matrix proteins, such as Laminin β2 (S-laminin), which are secreted and not anchored in the membrane,
mark ‘synaptic’ sites in Rapsyn mutant mice. AChRs are enriched in the central region of Rapsyn mutant
muscle, due to synapse-specific transcription, but neither AChRs nor other postsynaptic membrane
proteins are anchored in the ‘synaptic’ membrane, marked by S-laminin [106]. MuSK appears unique
among transmembrane proteins, as MuSK is concentrated at defunct ‘synaptic’ sites in the absence of
Rapsyn [107]. Whether Lrp4, which associates with MuSK, is likewise concentrated at ‘synaptic’ sites
in the absence of Rapsyn is not known.
Mutations in Rapsyn cause congenital myasthenia, and the most common mutation occurs at N88
in the third TPR repeat. The TPR repeats in Rapsyn, which can associate with one another, as well as
bind Macf1, have been proposed to play a direct role in Rapsyn oligomerization and indirectly in
AChR clustering [98,102]. Surprisingly, given that the TPR repeats are thought to regulate Rapsyn
oligomerization, whereas the coiled-coil region is thought to mediate association with AChRs, mutation
of N88 does not alter the ability of Rapsyn to self-cluster but instead impairs the ability of Rapsyn to
cluster AChRs in 293 cells transfected with Rapsyn and AChR subunit cDNAs [108].
Rapsyn-mediated neddylation of AChRs, mediated by the RING finger in Rapsyn, plays
an important role in clustering AChRs [101]. Addition of NEDD8 may be instructive for AChR
clustering, possibly by serving as a recruitment motif for scaffolding proteins that anchor AChRs.
Understanding how neddylation regulates AChR clustering, including Identification of proteins that
may be recruited to neddylated AChRs, would be an important step forward.
Rapsyn is associated with AChRs in post-Golgi vesicles [109,110], so it is possible that Rapsyn
has a role in directing transport vesicles to the postsynaptic membrane, as well as anchoring AChRs
and other postsynaptic proteins in the plasma membrane. A further and better understanding of how
Rapsyn targets and anchors postsynaptic proteins remains a burning and important question.
Rapsyn is associated with non-clustered AChRs, present on myotubes in the absence of Agrin
stimulation and in extrasynaptic regions of denervated muscle, indicating that Rapsyn recruitment,
on its own, is insufficient to stimulate AChR clustering [111]. Instead, these findings suggest
that Agrin-stimulation alters Rapsyn or Rapsyn-associated proteins so that pre-bound Rapsyn now
functions as an anchoring protein. The biochemical changes that follow MuSK stimulation and lead to
Rapsyn clustering are not well understood.
Agrin stimulates tyrosine phosphorylation of the AChR β subunit, leading to recruitment
of Rapsyn to the tyrosine phosphorylated β subunit and therefore additional Rapsyn bound to
AChRs [96,111]. Preventing β subunit tyrosine phosphorylation inhibits this additional recruitment
but does not block Agrin-stimulated clustering of AChRs, indicating that recruitment of Rapsyn to
the tyrosine phosphorylated AChR β subunit is not essential to cluster AChRs [112]. Nonetheless,
preventing AChR β subunit tyrosine phosphorylation leads to defects in development of postjunctional
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folds, a reduction in the density of synaptic AChRs and renders clustered AChRs more labile, indicating
that this further recruitment of Rapsyn assists in stabilizing AChRs that are clustered at synapses or
in muscle cells treated with Agrin [112]. Structural studies of AChR-rich electric organ membranes
containing Rapsyn present a model that may explain how recruitment of Rapsyn to the tyrosine
phosphorylated AChR β subunit may stabilize AChR clusters, as three unlike two molecules of Rapsyn
are predicted to form an extensive cross-linked network of AChRs that would presumably stabilize
AChRs [113].
3. Steps in Synapse Formation
3.1. Muscle Prepatterning
Nearly twenty years ago it became clear that postsynaptic differentiation could be initiated in
muscle in the absence of Agrin or indeed motor neurons [114–118]. These studies pointed to the ability
of muscle to become pre-patterned or specialized in the prospective synaptic region in the absence of
signals from motor neurons (Figure 2). Muscle pre-patterning, like synapse formation, requires MuSK.
In zebrafish, MuSK is activated during pre-patterning by muscle-derived Wnts, which bind the Fz-like
domain in MuSK [119]; in mice, MuSK is activated during pre-patterning by Lrp4 [57], which binds to
the first Ig-like domain in MuSK [60]. The role of the MuSK Fz-like domain during synapse formation
is controversial: in zebrafish, the Fz-like domain is dispensable for synapse formation [119], whereas
conflicting results have been reported for the importance of the Fz-like domain in synapse formation
in mice [120,121] (Figure 2).
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Figure 2. Steps in the formation of neuromuscular synapses.
During development, prior to and independent of innervation, AChRs are clustered in the
prospective synaptic region of muscle. Innervation provides two signals that refine and sharpen
this prepatterned arrangement so that AChRs become restricted to synaptic sites: ACh depolarizes
muscle, which disperses AChR clusters, whereas Agrin activates MuSK, focally stabilizing AChRs in
the muscle membrane that is in apposed to nerve terminals.
Muscle pre-patterning has a role in directing synapses to form in the central region of mammalian
muscle. Once motor axons arrive in the muscle, usually entering near the center of the muscle,
independent of MuSK [35,58], they branch from the main intramuscular nerve in a stereotyped manner,
recognizing the pre-patterned region, and forming synapses adjacent to the main intramuscular
nerve near the center of the muscle [58] (Figure 2). Motor neuron-derived Agrin then binds to Lrp4,
potentiating the association between Lrp4 and MuSK and substantially increasing MuSK [39,59,60],
thereby enhancing the pathways for anchoring postsynaptic proteins and synapse-specific transcription
(Figure 3). As such, Agrin serves to form, consolidate and stabilize neuromuscular synapses.
Int. J. Mol. Sci. 2018, 19, 490 11 of 19
Int. J. Mol. Sci. 2018, 18, x FOR PEER REVIEW  11 of 19 
 
 
Figure 3. Mechanism for forming and maintaining neuromuscular synapses. 
Prepatterning requires Lrp4 and MuSK. Lrp4 binds to MuSK and stimulates MuSK 
phosphorylation, which is stabilized by Dok-7. Upon innervation, motor neuron-derived Agrin binds 
to Lrp4, further stimulating the interaction between Lrp4 and MuSK, increasing MuSK 
phosphorylation, and promoting downstream signaling. 
3.2. Stabilizing and Dispersing AChR Clusters 
The pre-patterned distribution of AChRs requires Lrp4 and MuSK [57,116,117,121]. Because 
Lrp4 binds to and stimulates MuSK, Lrp4 acts a cis-acting ligand for MuSK. Once activated by Lrp4, 
MuSK stimulates the clustering not only of AChRs but also of MuSK and Lrp4 [29,122]. Clustered 
Lrp4 then functions as a retrograde signal to motor neurons, causing motor axons to stop growing 
and to form specialized nerve terminals [71]. Agrin, released from nerve terminals, binds to Lrp4, 
stimulating an increase in association between Lrp4 and MuSK and a substantial increase in MuSK 
tyrosine phosphorylation [39,59,60]. As such, Lrp4 functions as a checkpoint at these three sequential 
steps in synapse formation, since each subsequent step cannot be executed without completion of the 
preceding Lrp4-dependent step. 
Studies of the requirements for Agrin in muscle pre-patterning and innervation led to a 
hypothesis suggesting that innervation provides a second signal, in addition to Agrin, which assists 
in converting the pre-patterned distribution of AChR clusters to the more spatially restricted 
distribution of AChR clusters confined to synapses [116,117]. In this model, the Agrin/Lrp4/MuSK 
pathway acts to form and maintain postsynaptic differentiation, including AChR clustering, whereas 
the second nerve-derived signal, ACh, counteracts the clustering activity of Agrin by stimulating 
dispersal/removal of AChR clusters that are not opposed by nerve terminals and Agrin [123,124]. The 
mechanism by which ACh disperses AChR clusters is not well understood, but it appears that 
Calpain, a protease, as well as Cdk5, a serine/threonine kinase, play a role [123,125,126]. ACh 
treatment of cultured muscle cells increases the activities of Calpain and Cdk5, and the increase in 
Cdk5 activity is dependent upon Calpain. The ACh-mediated increase in Calpain/Cdk5 activity 
Figure 3. Mechanism for forming and maintaining neuromuscular synapses.
Prepatterning requires Lrp4 and MuSK. Lrp4 binds to MuSK and stimulates MuSK phosphorylation,
which is stabilized by Dok-7. Upon innervation, motor neuron-derived Agrin binds to Lrp4,
further stimulating the interaction between Lrp4 and MuSK, increasing MuSK phosphorylation,
and promoting downstream signaling.
3.2. Stabilizing and Dispersing AChR Clusters
The pre-patterned distribution of AChRs requires Lrp4 and MuSK [57,116,117,121]. Because Lrp4
binds to and stimulates MuSK, Lrp4 acts a cis-acting ligand for MuSK. Once activated by Lrp4, MuSK
stimulates the clustering not only of AChRs but also of MuSK and Lrp4 [29,122]. Clustered Lrp4 then
functions as a retrograde signal to motor neurons, causing motor axons to stop growing and to form
specialized nerve terminals [71]. Agrin, released from nerve terminals, binds to Lrp4, stimulating
an increase in association between Lrp4 and MuSK and a substantial increase in MuSK tyrosine
phosphorylation [39,59,60]. As such, Lrp4 functions as a checkpoint at these three sequential steps in
synapse formation, since each subsequent step cannot be executed without completion of the preceding
Lrp4-dependent step.
Studies of the requirements for Agrin in muscle pre-patterning and innervation led to a hypothesis
suggesting that innervation provides a second signal, in addition to Agrin, which assists in converting
the pre-patterned distribution of AChR clusters to the more spatially restricted distribution of AChR
clusters confined to synapses [116,117]. In this model, the Agrin/Lrp4/MuSK pathway acts to form and
maintain postsynaptic differentiation, including AChR clustering, whereas the second nerve-derived
signal, ACh, counteracts the clustering activity of Agrin by stimulating dispersal/removal of AChR
clusters that are not opposed by nerve terminals and Agrin [123,124]. The mechanism by which ACh
disperses AChR clusters is not well understood, but it appears that Calpain, a protease, as well as Cdk5,
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a serine/threonine kinase, play a role [123,125,126]. ACh treatment of cultured muscle cells increases
the activities of Calpain and Cdk5, and the increase in Cdk5 activity is dependent upon Calpain.
The ACh-mediated increase in Calpain/Cdk5 activity promotes dispersal of AChR clusters. In contrast,
Agrin stimulates recruitment of Calpain to the TPR repeats in Rapsyn (see below), inhibiting Calpain
activity. Much remains unknown: how does ACh stimulate Calpain activity; how does Rapsyn reduce
Calpain activity; how does Agrin stimulate recruitment of Calpain to Rapsyn; does ACh alter the
association between Calpain and Rapsyn; does Calpain have substrates other than p25/Cdk5, such as
links between AChR/Rapsyn and a cytoskeleton, which could disperse AChR clusters? Moreover,
because manipulating Calpain activity has a modest effect on dispersal of AChR clusters, additional
pathways may act downstream from ACh to disassemble AChR clusters that are not contacted by
nerve terminals and stabilized by Agrin.
3.3. Synapse Elimination and Maturation
During embryonic development, the single synaptic site on individual muscle fibers is innervated
by approximately half dozen motor axons. Over the next several weeks, synapses are eliminated,
so that each myofiber is ultimately innervated by a single motor axon. This rearrangement leads to a
reduction in the number of muscle fibers innervated by each motor neuron (motor unit size) without a
loss of motor neurons. The mechanisms responsible for this regulated pruning are not understood but
appear to require competition among motor axon terminals, favoring the survival of the most active
terminal at individual synapses [127]. Given the stabilizing role for Agrin/MuSK signaling, and the
extinguishing role for ACh signaling during earlier steps in synapse formation, one wonders whether
the same signaling system is employed later to regulate synapse elimination and editing.
Following these early steps in synapse formation, the structure and function of the neuromuscular
synapse continues to mature [14,128]. Proteins that are required for the formation of synapses are
invariably required for their maturation, but certain proteins, such as Src-family kinases, dystrobrevin
and Neuregulin-1 play roles in the maturation and stabilization yet are not essential for the formation of
neuromuscular synapses [91,129–135]. How these and other proteins regulate later steps in maturation
is poorly understood.
3.4. Targets for Therapy to Maintain Neuromuscular Synapses and Reduce Denervation
Manipulation of the signaling mechanisms that are responsible for maintaining attachment of
motor nerve terminals to muscle holds promise for neuromuscular and neurodegenerative diseases
that are hallmarked by neuromuscular dysfunction and axon withdrawal [136–139].
In SOD1 G93A mice, a mouse model for amyotrophic lateral sclerosis (ALS), boosting retrograde
signaling by modestly increasing MuSK gene expression decreases the rate and extent of denervation
and improves motor performance [136]. Raising the levels of Dok-7 gene expression in mice, either by
adenoviral gene transfer or a Dok-7 transgene stimulates MuSK phosphorylation and increases synaptic
size [84]. In mouse models for congenital Dok-7 myasthenia, Emery-Dreifuss muscular dystrophy or
ALS, a boost in Dok-7 gene expression suppresses motor axon withdrawal, improves motor function
and extends life span [137,139]. Although gene therapy in skeletal muscle remains a daunting approach,
these findings suggest that similar approaches hold promise.
4. Conclusions and Discussion
Over the past two decades we have gained insight into the molecules and mechanisms by
which motor neurons and myofibers communicate and instruct each other to form and maintain
a synapse. Nevertheless, key aspects of these well-orchestrated interactions remain unclear.
For example, Lrp4 is a critical retrograde signal for instructing motor axons to stop growing and
to differentiate [71], but the presynaptic Lrp4 receptor and the mechanisms that mediate growth
arrest and presynaptic differentiation are unknown. Moreover, because defects in the function
of the Agrin/Lrp4/MuSK/Dok-7/Rapsyn pathway are responsible for neuromuscular disease,
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autoantibodies to the extracellular receptor of the Lrp4 receptor and mutations in this receptor may be
responsible for myasthenia as well.
A loss of function in Agrin, Lrp4, MuSK, Dok-7, or Rapsyn results in a failure to form neuromuscular
synapses, leading to respiratory failure and neonatal lethality. Despite the critical importance of these
genes in synapse formation and survival, no other genes act in a redundant manner and serve as
‘back-up’ genes. AChRs are expressed in the postsynaptic membrane in 3- to 5-fold excess of that
required for ACh to elicit an action potential and muscle contraction. Although this safety factor
cannot overcome a complete loss of Agrin, Lrp4, MuSK, Dok-7 ,or Rapsyn function, this excess in
AChR expression, particularly at the crests of the postjunctional folds directly across from active zones
in the nerve terminal, may permit synapses to function well enough to allow for survival in instances
when the activity of these essential synaptic proteins is reduced, possibly alleviating the precarious
nature of single, non-redundant genes for an essential function.
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